Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)
Clinical trial NCT04470622 · TERMINATED
Trial details
- NCT number
- NCT04470622
- Sponsor
- Heron Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2021-04-09
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.